Literature DB >> 24765676

Deficits in cognitive function and hippocampal plasticity in GM2/GD2 synthase knockout mice.

Sha Sha, Libin Zhou, Jun Yin, Koga Takamiya, Keiko Furukawa, Koichi Furukawa, Masahiro Sokabe, Ling Chen.   

Abstract

In this study, we used GM2/GD2 synthase knockout (GM2/GD2−/−) mice to examine the influence of deficiency in ganglioside “a-pathway” and “b-pathway” on cognitive performances and hippocampal synaptic plasticity. Eight-week-old GM2/GD2−/− male mice showed a longer escape-latency in Morris water maze test and a shorter latency in step-down inhibitory avoidance task than wild-type (WT) mice. Schaffer collateral-CA1 synapses in the hippocampal slices from GM2/GD2−/− mice showed an increase in the slope of EPSPs with reduced paired-pulse facilitation, indicating an enhancement of their presynaptic glutamate release. In GM2/GD2−/− mice, NMDA receptor (NMDAr)-dependent LTP could not be induced by high-frequency (100–200 Hz) tetanus or θ-burst conditioning stimulation (CS), whereas NMDAr-independent LTP was induced by medium-frequency CS (20–50 Hz). The application of mono-sialoganglioside GM1 in the slice from GM2/GD2−/− mice, to specifically recover the a-pathway, prevented the increased presynaptic glutamate release and 20 Hz-LTP induction, whereas it could not rescue the impaired NMDAr-dependent LTP. These findings suggest that b-pathway deficiency impairs cognitive function probably through suppression of NMDAr-dependent LTP, while a-pathway deficiency may facilitate NMDAr-independent LTP through enhancing presynaptic glutamate release. As both of the NMDAr-independent LTP and increased presynaptic glutamate release were sensitive to the blockade of L-type voltage-gated Ca2+ channels (L-VGCC), a-pathway deficiency may affect presynaptic L-VGCC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24765676     DOI: 10.1002/hipo.22230

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  5 in total

1.  Neuronopathic Gaucher disease: dysregulated mRNAs and miRNAs in brain pathogenesis and effects of pharmacologic chaperone treatment in a mouse model.

Authors:  Nupur Dasgupta; You-Hai Xu; Ronghua Li; Yanyan Peng; Manoj K Pandey; Stuart L Tinch; Benjamin Liou; Venette Inskeep; Wujuan Zhang; Kenneth D R Setchell; Mehdi Keddache; Gregory A Grabowski; Ying Sun
Journal:  Hum Mol Genet       Date:  2015-09-29       Impact factor: 6.150

Review 2.  Simplifying complexity: genetically resculpting glycosphingolipid synthesis pathways in mice to reveal function.

Authors:  Maria Laura Allende; Richard L Proia
Journal:  Glycoconj J       Date:  2014-10-29       Impact factor: 2.916

3.  Attenuation of Bone Formation through a Decrease in Osteoblasts in Mutant Mice Lacking the GM2/GD2 Synthase Gene.

Authors:  Eri Sasaki; Kazunori Hamamura; Yoshitaka Mishima; Koichi Furukawa; Mayu Nagao; Hanami Kato; Kosuke Hamajima; Takuma Sato; Ken Miyazawa; Shigemi Goto; Akifumi Togari
Journal:  Int J Mol Sci       Date:  2022-08-12       Impact factor: 6.208

4.  Disease-modifying effects of ganglioside GM1 in Huntington's disease models.

Authors:  Melanie Alpaugh; Danny Galleguillos; Juan Forero; Luis Carlos Morales; Sebastian W Lackey; Preeti Kar; Alba Di Pardo; Andrew Holt; Bradley J Kerr; Kathryn G Todd; Glen B Baker; Karim Fouad; Simonetta Sipione
Journal:  EMBO Mol Med       Date:  2017-11       Impact factor: 12.137

5.  Plasma Membrane Calcium ATPase-Neuroplastin Complexes Are Selectively Stabilized in GM1-Containing Lipid Rafts.

Authors:  Katarina Ilic; Xiao Lin; Ayse Malci; Mario Stojanović; Borna Puljko; Marko Rožman; Željka Vukelić; Marija Heffer; Dirk Montag; Ronald L Schnaar; Svjetlana Kalanj-Bognar; Rodrigo Herrera-Molina; Kristina Mlinac-Jerkovic
Journal:  Int J Mol Sci       Date:  2021-12-18       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.